Source: School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Nielsen(Copenhagen, Denmark). Clinical trials and outcome measures. School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe

Member's Comments

No comment yet.

Related content which might interest you: Clinical trials based on biomarkers Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Current clinical trials Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 Quality control in clinical trials Source: Annual Congress 2007 - Quality control in respiratory medicine and research Year: 2007 Surrogate outcome measures Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis Year: 2012 Publication rate and characteristics of industry-sponsored asthma clinical trials Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Clinical trials design in the age of precision medicine Source: ERS webinar 2020: Clinical trials design in the age of precision medicine Year: 2020 Patient-reported outcome measures after COVID-19: a prospective cohort study Source: Eur Respir J, 56 (5) 2003276; 10.1183/13993003.03276-2020 Year: 2020 Clinical trials: registration and transparency Source: Eur Respir J 2016; 47:1342-1344 Year: 2016 Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021 Biological quality control for spirometry in a multi-centred clinical trial Source: Annual Congress 2008 - Quality spirometry: the only spirometry! Year: 2008 Trends in primary outcome parameters for respiratory trials. Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 CoVID 19: clinical characteristics and outcome Source: Virtual Congress 2020 – Hot topics in intensive care: COVID-19: Lessons learned Year: 2020 Quality assurance in clinical trials Source: Annual Congress 2009 - Quality and accreditation in lung function Year: 2009 Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 PROMising developments in IPF patient-reported outcome measures Source: Eur Respir J, 59 (1) 2102312; 10.1183/13993003.02312-2021 Year: 2022 Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures Source: Eur Respir J 2005; 26: 755-758 Year: 2005 Patient perspective of participation in COVID-19 clinical trials Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021 Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006